Crospovidone Granules Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Crospovidone Granules

Crospovidone Granules are pharmaceutical-grade granulated material based on cross-linked polyvinylpyrrolidone, also known as crospovidone or cross-linked PVP. Crospovidone is a synthetic, water-insoluble cross-linked homopolymer of N-vinyl-2-pyrrolidone and is used as a functional pharmaceutical excipient, particularly as a superdisintegrant in oral solid formulations. USP-NF identifies Crospovidone under the chemical description of 1-ethenyl-2-pyrrolidinone homopolymer and gives CAS Number 9003-39-8.

The granulated presentation provides a controlled physical form for pharmaceutical formulation and manufacturing applications. Depending on the manufacturing process and intended application, granule characteristics such as particle-size distribution, moisture, bulk density and flow can influence processing and formulation performance.

What is Crospovidone?

Crospovidone is a cross-linked homopolymer of N-vinyl-2-pyrrolidone. Unlike soluble povidone, crospovidone is water-insoluble because of its cross-linked polymer structure. USP-NF specifies that Crospovidone contains 11.0% to 12.8% nitrogen, calculated on the dried basis.

Crospovidone is also commonly described as:

  • Cross-Linked Polyvinylpyrrolidone
  • Cross-Linked PVP
  • Polyvinylpolypyrrolidone
  • PVPP
  • Crospovidone

The CAS Number for Crospovidone is 9003-39-8.

Crospovidone Granules for Pharmaceutical Formulations

Crospovidone Granules provide the cross-linked polymer in a granulated physical format. The material can be considered for formulation systems where controlled excipient handling and consistent physical characteristics are required.

Potential material characteristics include:

  • Particle-size distribution
  • Granule size
  • Moisture content
  • Bulk density
  • Tapped density
  • Flow characteristics
  • Fines content
  • Water-insoluble character
  • Batch-to-batch consistency

These physical properties should be reported according to the actual SDP product specification.

Pharmaceutical Excipient Function

Crospovidone is primarily used as a superdisintegrant. Its cross-linked structure allows it to absorb water and promote rapid breakup of suitable solid formulations.

Crospovidone is used in pharmaceutical formulation development for tablets, capsules and other oral solid dosage systems. Its performance can depend on grade, particle size, concentration, formulation composition and manufacturing process.

Type A and Type B Crospovidone

USP-NF identifies two types of Crospovidone based on particle size: Type A and Type B.

For SDP, the actual type should be specified only according to the product specification.

Type: Type A / Type B

Do not assign a type solely from the product name.

Granule Particle Size

Particle size is particularly important for Crospovidone because USP-NF recognizes different Crospovidone types based on particle size.

For a granulated product, SDP can additionally specify:

Particle Size: [Actual SDP specification]

Where validated data are available:

D10: [Value]
D50: [Value]
D90: [Value]

These values should not be invented because the appropriate granule size depends on the specific product grade and manufacturing process.

Water Insolubility

Crospovidone is a water-insoluble cross-linked polymer. Its water-insoluble nature distinguishes it from soluble povidone and contributes to its functionality as a disintegrant. USP-NF explicitly defines Crospovidone as water-insoluble.

Quality Characteristics

Crospovidone has established pharmacopeial quality requirements. These include identity, nitrogen content, pH, water/loss on drying, residue on ignition, water-soluble substances and limits for relevant impurities.

USP-NF specifies 11.0–12.8% nitrogen on the dried basis.

Published USP material specifies:

  • pH: 5.0–8.0
  • Water: NMT 5.0%
  • Residue on ignition: NMT 0.4%
  • Water-soluble substances: NMT 1.5% 

Quality Control

Quality control of Crospovidone can include:

  • Identification
  • Nitrogen content
  • pH
  • Loss on drying/water
  • Residue on ignition
  • Water-soluble substances
  • Relevant residual monomer testing
  • Peroxide testing
  • Microbial quality, where applicable

USP has specifically identified peroxide and vinylpyrrolidone testing as relevant Crospovidone quality controls.

Applications of Crospovidone Granules

Crospovidone Granules may be considered for:

  • Tablet formulations
  • Capsule formulations
  • Oral solid dosage formulations
  • Immediate-release formulations
  • Granulated pharmaceutical formulations
  • Direct-compression formulation development
  • Superdisintegrant applications
  • Pharmaceutical excipient systems

The actual use level should be established during formulation development according to the formulation composition and manufacturing process.

Why Crospovidone Granules from Swapnroop?

  • Pharmaceutical-Grade Granules
  • Cross-Linked PVP-Based Excipient
  • Controlled Granule Characteristics
  • Consistent Excipient Quality
  • Controlled Moisture and Physical Properties
  • Formulation Flexibility
  • Bulk Pharmaceutical Supply

Storage and Handling

Crospovidone should be protected from unsuitable environmental exposure and stored in appropriate packaging. USP material specifies preservation in tight containers.

For Crospovidone Granules, the final storage conditions should follow the actual SDP product specification and packaging requirements.

Detailed Specifications

Parameter Specification
Appearance white to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 98.0% – 102.0%
Loss on Drying NMT 1.0%
Residue on Ignition NMT 0.1%
Heavy Metals NMT 10 ppm
Individual Impurity NMT 0.5%
Water Content NMT 1.0%
Get Bulk Quote via WhatsApp